Cargando…
A novel model associated with tumor microenvironment on predicting prognosis and immunotherapy in triple negative breast cancer
Triple negative breast cancer (TNBC) is the most aggressive and malignant subtype in breast cancer. Immunotherapy is a currently promising and effective treatment for TNBC, while not all patients are responsive. Therefore, it is necessary to explore novel biomarkers to screen sensitive populations f...
Autores principales: | Zhang, Juan, Zhang, Mi, Tian, Qi, Yang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618350/ https://www.ncbi.nlm.nih.gov/pubmed/37219794 http://dx.doi.org/10.1007/s10238-023-01090-5 |
Ejemplares similares
-
Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023) -
Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
por: Kudelova, Eva, et al.
Publicado: (2022) -
Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
por: Huang, Pengfei, et al.
Publicado: (2023) -
92418 Molecular imaging of the tumor microenvironment to predict response to combination treatment with immunotherapy in triple negative breast cancer
por: Napier, Tiara S., et al.
Publicado: (2021) -
Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
por: Zhang, Jinguo, et al.
Publicado: (2023)